Victoria Hsiao, MD, PhD

Associate Professor

Dr. Hsiao, originally from Boulder, Colorado, received her B.A. magna cum laude in Biology from Harvard University, her Ph.D. in Pathobiology from Columbia University, and her M.D. from the College of Physicians and Surgeons of Columbia University. She completed her residency training in Internal Medicine at the Johns Hopkins Hospital, and completed her fellowship training in the Division of Metabolism, Endocrinology, and Diabetes at the University of Michigan Hospital. She served as an Assistant Professor at the University of Rochester Medical Center from 2010-2016. She joined the University of California – San Francisco as an Associate Clinical Professor in December 2016.

Dr. Hsiao's clinical interests are in diabetes and lipid disorders. Dr. Hsiao's research interests include patient, provider, and health plan factors affecting delivery of diabetes care and health outcomes. Her research findings have been published in the Journal of Cell Science, Diabetes Care, American Journal of Managed Care, Pharmacoepidemiology and Drug Safety, and the Journal of Clinical Endocrinology and Metabolism. She was also the recipient of the 2009 Lilly Endocrine Scholars Award from The Endocrine Society for her research on how high blood glucose levels affect bone marrow transplantation outcomes.
Education
MD, - Medicine, Columbia University College of Physicians and Surgeons
PhD, - Pathobiology, Columbia University Graduate School of Arts and Sciences
BA magna cum laude, - Biology, Harvard University
- Internal Medicine (internship and residency), Johns Hopkins Hospital
- Metabolism, Endocrinology and Diabetes (fellowship), University of Michigan Hospital
Honors and Awards
  • Board Certified in Endocrinology, Diabetes and Metabolism, American Board of Internal Medicine, 2010
  • Lilly Endocrine Scholars Award Winner, The Endocrine Society, 2009-2010
  • Board Certified in Internal Medicine, American Board of Internal Medicine, 2007-2017
Publications
  1. Huang J, Yeung AM, DuBord AY, Wolpert H, Jacobs PG, Lee WA, Drincic A, Spanakis EK, Sherr JL, Prahalad P, Fleming A, Hsiao VC, Kompala T, Lal RA, Fayfman M, Ginsberg BH, Galindo RJ, Stuhr A, Chase JG, Najafi B, Masharani U, Seley JJ, Klonoff DC. Diabetes Technology Meeting 2022. Journal of diabetes science and technology 2023. PMID: 36704821


  2. King F, Ahn D, Hsiao V, Porco T, Klonoff DC. A Review of Blood Glucose Monitor Accuracy. Diabetes technology & therapeutics 2018. PMID: 30376362


  3. Bilik D, McEwen LN, Brown MB, Pomeroy NE, Kim C, Asao K, Crosson JC, Duru OK, Ferrara A, Hsiao VC, Karter AJ, Lee PG, Marrero DG, Selby JV, Subramanian U, Herman WH. Thiazolidinediones and fractures: evidence from translating research into action for diabetes. The Journal of clinical endocrinology and metabolism 2010. PMID: 20631021


  4. Bilik D, McEwen LN, Brown MB, Selby JV, Karter AJ, Marrero DG, Hsiao VC, Tseng CW, Mangione CM, Lasser NL, Crosson JC, Herman WH. Thiazolidinediones, cardiovascular disease and cardiovascular mortality: translating research into action for diabetes (TRIAD). Pharmacoepidemiology and drug safety 2010. PMID: 20583206


  5. McEwen LN, Hsiao VC, Nota-Kirby EM, Kulpa GJ, Schmidt KG, Herman WH. Effect of a managed care disease management program on diabetes care. The American journal of managed care 2009. PMID: 19747021


  6. Hsiao VC, Tian R, Long H, Der Perng M, Brenner M, Quinlan RA, Goldman JE. Alexander-disease mutation of GFAP causes filament disorganization and decreased solubility of GFAP. Journal of cell science 2005. PMID: 15840648